Back to Search Start Over

Rebalance the oral microbiota as efficacy tool in endocrine, metabolic, and immune disorders

Authors :
Ciro Gargiulo Isacco
Andrea Ballini
Danila De Vito
Kieu Cao Diem Nguyen
Stefania Cantore
Lucrezia Bottalico
Lucio Quagliuolo
Mariarosaria Boccellino
Marina Di Domenico
Luigi Santacroce
Roberto Arrigoni
Gianna Dipalma
Francesco Inchingolo
Isacco, Ciro Gargiulo
Ballini, Andrea
De Vito, Danila
Nguyen, Kieu Cao Diem
Cantore, Stefania
Bottalico, Lucrezia
Quagliuolo, Lucio
Boccellino, Mariarosaria
Di Domenico, Marina
Santacroce, Luigi
Arrigoni, Roberto
Dipalma, Gianna
Inchingolo, Francesco
Source :
Endocrine, metabolic & immune disorders. Drug targets, (2020). doi:10.2174/1871530320666200729142504, info:cnr-pdr/source/autori:Ciro Gargiulo Isacco, Andrea Ballini, Danila De Vito, Kieu Cao Diem Nguyen, Stefania Cantore, Lucrezia Bottalico, Lucio Quagliuolo, Mariarosaria Boccellino, Marina Di Domenico, Luigi Santacroce, Roberto Arrigoni, Gianna Dipalma, Francesco Inchingolo/titolo:Rebalance the oral microbiota as efficacy tool in endocrine, metabolic, and immune disorders/doi:10.2174%2F1871530320666200729142504/rivista:Endocrine, metabolic & immune disorders. Drug targets (Print)/anno:2020/pagina_da:/pagina_a:/intervallo_pagine:/volume
Publication Year :
2020

Abstract

The current treatment and prevention of oral disorders follow a very sectoral control and procedures considering mouth and its structures as system completely independent from the rest of the body. The main therapeutic approach is carried out on just to keep the levels of oral bacteria and hygiene in an acceptable range compatible with one-way vision of oral-mouth health completely separated from a systemic microbial homeostasis (eubiosis vs dysbiosis). This can negatively impact on the diagnosis of more complex systemic disease and its progression. Dysbiosis is consequence of oral and gut microbiota unbalance with consequences, as reported in current literature, in cardio vascular disease, diabetes mellitus, rheumatoid arthritis, and Alzheimer's disease. Likewise, there is the need to highlight and develop a novel philosophical approach in the treatments for oral diseases that will necessarily involve non-conventional approaches.

Details

Language :
English
Database :
OpenAIRE
Journal :
Endocrine, metabolic & immune disorders. Drug targets, (2020). doi:10.2174/1871530320666200729142504, info:cnr-pdr/source/autori:Ciro Gargiulo Isacco, Andrea Ballini, Danila De Vito, Kieu Cao Diem Nguyen, Stefania Cantore, Lucrezia Bottalico, Lucio Quagliuolo, Mariarosaria Boccellino, Marina Di Domenico, Luigi Santacroce, Roberto Arrigoni, Gianna Dipalma, Francesco Inchingolo/titolo:Rebalance the oral microbiota as efficacy tool in endocrine, metabolic, and immune disorders/doi:10.2174%2F1871530320666200729142504/rivista:Endocrine, metabolic & immune disorders. Drug targets (Print)/anno:2020/pagina_da:/pagina_a:/intervallo_pagine:/volume
Accession number :
edsair.dedup.wf.001..3fa8846bf705c8d0d6c92512e81fcc89